HER2
A molecular target whose expression can matter across anatomically different cancers.
VOCE Atlas · Documented relation
HER2 ↔ Biliary tract cancer
HER2 defines a targetable subgroup within Biliary tract cancer.
Documented relation
HER2 defines a targetable subgroup within Biliary tract cancer.
Relation classDirect evidence
A descriptive, taxonomic, historical, clinical or institutional relation directly supported by the cited record without claiming a stronger mechanism.
Inference prohibited
Do not generalize this relation beyond the population, system, period or documentary scope supported by the cited record.
Evidence
What supports this relation.
Record context
Biliary tract cancer
A cancer category in which a HER2-positive subgroup may define a distinct therapeutic vulnerability.
Questions before professional use
Which precise statement does the source support, for which period and scope? Distinguish that finding from extrapolation to the case under review.
Evidence links lead to VOCE records. Consult their primary references and scope before adopting a conclusion or applying it to a situation.
Relations to examine in the same context
Cite this record
VOCE Association. HER2 ↔ Biliary tract cancer. VOCE Atlas. Identifier: her2--biliary-cancer. Graph version: 2026-10-06. https://voce.life/atlas/relations/her2--biliary-cancer
Read the graph dataMethod
What this page asserts.
This page preserves one published relation in VOCE Atlas, its authored source-target wording, semantic class, evidence and inference boundary. Graph traversal remains non-directional and does not license a causal upgrade.